Lv21
190 积分 2023-08-04 加入
Treatments for esophageal cancer: a review
35分钟前
待确认
Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first‐line treatment of advanced esophageal squamous cell carcinoma
2小时前
已完结
Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first‐line treatment of advanced esophageal squamous cell carcinoma
11个月前
已完结
An Exploration of Trifluridine/Tipiracil Monotherapy and in Combination With Bevacizumab or Immune Checkpoint Inhibitors for Patients With Metastatic Colorectal Cancer: A Real-World Study
1年前
已完结
Positive-Sample-Based Surface Defect Detection Using Memory-Augmented Adversarial Autoencoders
1年前
已完结
Commensal fungi in intestinal health and disease
1年前
已完结
Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohorts
1年前
已完结
ASO Author Reflections: Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma
1年前
已完结
Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial
1年前
已完结
Conversion therapy for stage IV gastric cancer
1年前
已完结
皖公网安备34019202002308
